Headline Expenditure Projections Pharmaceuticals: TRY17.16bn (USD9.00bn) in 2013 to TRY18.79bn (USD8.37bn) in 2014; +9.5% in local currency and -7.1% US dollar terms.
Healthcare: TRY108.64bn (USD57.01bn) in 2013 to TRY118.15bn (USD52.63bn) in 2014; +8.8% in local currency and -7.7% US dollar terms.
Inquire before Buying @ http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=13785 .
Table Of Contents
BMI Industry View 7
SWOT 9
Political 11
Economic 13
Business Environment 14
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Turkey 2010-2018) 17
Healthcare Market Forecast 18
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2010-2018) 19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2010-2018) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2010-2018) 20
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Turkey 2010-2018) 22
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Turkey 2010-2018) 23
Generic Drug Market Forecast 24
Table: Generics Drug Market Indicators, Historical Data And Forecasts (Turkey 2010-2018) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Turkey 2010-2018) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Turkey 2012-2018) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Turkey 2012-2018) 29
Key Risks To BMI's Forecast Scenario 29
Macroeconomic Forecasts 31
Table: Turkey - GDP By Expenditure 38
Industry Risk Reward Ratings 39
Central And Eastern Europe Risk/Reward Ratings 39
Turkey Risk/Reward Ratings 46
Rewards 46
Risks 47
Market Overview 48
Industry Trends And Developments 50
Epidemiology 50
Healthcare Sector 51
Healthcare Insurance 52
Healthcare Infrastructure 52
Healthcare Financing 54
Research & Development 55
Clinical Trials 57
Regulatory Development 59
Intellectual Property Regime 60
Market Access Issues 63
Pricing Regime 64
Table: Turkish Pharmaceutical Pricing Decrees 66
Reimbursement Regime 67
Table: Pharmacist Discount Related To Annual Sales Revenue (VAT Excluded) 68
Competitive Landscape 69
Pharmaceutical Sector 69
Domestic Industry 70
Foreign Industry 71
Company Activity 72
Wholesale 73
Pharmaceutical Retail Sector 74
Company Profile 76
Abdi ?brahim 76
Eczaciba?i Healthcare 80
Sanovel Pharmaceuticals 84
EastPharma (Deva) 87
Mustafa Nevzat Ilac Sanayi (MN) Pharmaceuticals 91
Novartis 95
Pfizer 97
Sanofi 100
GlaxoSmithKline 103
Roche 106
AstraZeneca 109
Bayer 111
Merck & Co 113
Demographic Forecast 115
Demographic Outlook 115
Table: Turkey's Population By Age Group, 1990-2020 ('000) 116
Table: Turkey's Population By Age Group, 1990-2020 (% of population) 117
Table: Turkey's Key Population Ratios, 1990-2020 118
Table: Turkey's Rural And Urban Population, 1990-2020 118
Glossary 119
Methodology 121
Pharmaceutical Expenditure Forecast Model 121
Healthcare Expenditure Forecast Model 121
Notes On Methodology 122
Risk/Reward Ratings Methodology 123
Ratings Overview 124
Table: Pharmaceutical Risk/Reward Ratings Indicators 124
Indicator Weightings 125
Buy a copy of report @ http://www.lifescienceindustryresearch.com/purchase?rname=13785 .
Complete report is available @ http://www.lifescienceindustryresearch.com/turkey-pharmaceuticals-and-healthcare-report-q3-2014.html .
Contact sales@lifescienceindustryresearch.com / Call +1 888 391 5441 for further information on “Turkey Pharmaceuticals and Healthcare Report Q3 2014” report OR for any other market research and intelligence needs you may have for your business.
You May Also Find These Documents Helpful
-
The contribution made by the industry towards the GDP of the country is $ 1.2 trillion, which is 8.5% of the GDP (PWC, 2011). Increase in the wholesale prices of drugs during global financial crises has increased the expenditure to $ 10 billion, which increased to $ 300 billion in the year 2009. It has also increased the inflation rate in the country. In addition to this, it also has a negative impact on the Consumer Price Index, which fell to 1.3% in the year 2009 (Wilson, 2009). It is estimated that the retail drug industry would reach US$ 1420 billion in the year 2017 and there would be a compounded annual growth rate of 3.6% in the next 5 years (Reuters, 2012).…
- 1293 Words
- 6 Pages
Good Essays -
prescription drug market share, and prescription sales per store, and first on the list of Global…
- 277 Words
- 2 Pages
Good Essays -
According to a report released by CMS the national health expenditure is expected to increase on average of 6.1% from the year 2009 to 2019 (CMS, 2011). During this same projection period spending on Medicare is expected to raise an average of 6.9%, and Medicaid 7.9% per year. In 2009 spending on hospital related services in the United States were estimated at $761 billion dollars and will average an increase of 6.1% over the next decade (CMS, 2011). Spending on physician cost and clinical services will grow by 5.4% while prescription drug cost will grow 6.3% during the projected period (CMS, 2011).…
- 1633 Words
- 7 Pages
Best Essays -
Globally speaking, the US is regarded as a major player in the affairs of the world. As a major world power of the modern age, we lead the world into the future, and with a leading economy, and a reputation as a wealthy and advanced civilization, the facts about our expenses in the realm of healthcare are very surprising.…
- 504 Words
- 3 Pages
Good Essays -
Langreth, R. (2014, May). Big pharma 's favorite prescription: higher prices. , (), . Retrieved from…
- 575 Words
- 3 Pages
Satisfactory Essays -
As time has gone on the economics of health care have changed just as much. The supply and demand of health care and the products that are used in today economics the demand for health care is great. More people are becoming sick and need the treatment from the hospitals and doctors. Health care is accounts for about one-sixth of the entire economy, which is more than any other industry. In 2009 the health care total spending was around $2.5 trillion, with the most of that gross domestic product being about 18% - a measure of the value of all goods and services produced in…
- 851 Words
- 4 Pages
Good Essays -
Health expenditures in The United States inched toward $2.6 trillion in 2010. This is up 10…
- 1584 Words
- 7 Pages
Powerful Essays -
Expenditures has an impact on the health care industry, looking at this article “Health expenditures increased from 12.2 percent of the gross domestic product (GDP) to 13.5 percent in l997 (Levit et al. 1998), and they are expected to reach 16.6 percent of GDP in the year 2007 (Smith et al. 1998). The devotion of a large percentage of the total GDP to health costs is a concern because such dollars are then not available…
- 538 Words
- 3 Pages
Satisfactory Essays -
In light of an average American household expenditure, health care took 5.1% in 1989, 5.3% in 1999 and 5.9% in 2008. According to Pipes (2010), “In 2009, the United States spent 17.3% of its gross domestic product on healthcare, the highest in the world” (p. 23).…
- 2389 Words
- 7 Pages
Best Essays -
Annual spending on health care increased from $75 billion in 1970 to $2.0 trillion in 2005, and is estimated to reach $4 trillion in 2015. As a share of the economy, health care has more than doubled over the past 35 years, rising from 7.2% of GDP in 1970 to 16.0% of GDP in 2005, and is projected to be 20% of GDP in 2015. The annual rate of inflation of expenditure on health care 2002-2004 was about 8.4%, which far exceeded the rate of inflation for all other items in the United States economy ("How Changes in Medical Technology Affect Health Care Cost": 2007).…
- 1590 Words
- 7 Pages
Better Essays -
The United States spends more on health care than any other country in the entire world. The current level of national expenditures is astounding. According to us.governmentspending.com, the anticipated total of healthcare spending in the United States is $7,400.00 per person each year (Kaiser, 2009). Over the years the total of healthcare spending has continued to increase at a rapid rate. In 2009 healthcare costs accounted for 16% of the U.S. GDP ("Health care expenditures:," 2009 ). This paper will discuss different aspects of healthcare costs in the United States and what makes it better or what makes it worse.…
- 759 Words
- 4 Pages
Good Essays -
There are many reasons to why the costs in health care continue to increase. This cost increased started in the early 1990’s, health care expenditure increasing at a faster rate than the inflation, gross domestic product (GDP), or the population. In 2014, national health expenditures reach $5.4 trillion, or $18,709 per person. Some of the issues that contribute to expenditure increase were changes in population demographics, supply and demand; cost inflation, advances in new technology, and resources utilization. According to The Effect of Health Care Cost Growth on the U.S. Economy, (2014) the United States spends more on health care…
- 1145 Words
- 5 Pages
Better Essays -
At a NCSL Legislative Summit in August, 2013 it was noted that America spends, on average, nearly $9,000 per person on health care each year. The cost to the nation is $2.8 trillion, almost 18 percent of the GDP. The GDP is projected to be at 19.6 percent by 2021 (National Conference of State Legislation, 2013). In the projected years of 2011-2021 Medicare is expected to have a growth of 6.1% per year average over these years, Medicaid growth is expected to be 8.2% per year, private spending average per year 5.3%. By 2021, federal, state, and local government health care spending is projected to be nearly 50 percent of the national health expenditures, up from 46 percent in 2011, with federal spending accounting for about two-thirds of the government share (Centers for Medicare and Medicaid Services, 2013).…
- 2141 Words
- 9 Pages
Powerful Essays -
The "Healthcare/Pharmaceutical Asset Management Market [Wi-Fi RTLS, RFID (Tags – Active & Passive, Software), IR, Ultrasound, Equipment & Patient Tracking, Staff Safety, Temperature & Humidity Monitoring, Drug Counterfeit] - Global Forecast to 2017 " analyzes and studies the major market drivers, restraints, and opportunities in North America, Latin America, Europe, Asia, and Rest of the World.…
- 752 Words
- 4 Pages
Good Essays -
Pharmaceuticals: TZS693.94bn (USD429mn) in 2013 to an expected TZS806.32bn (USD498mn) in 2014; +16.2% growth in local currency terms and +16.1% in US dollar terms.…
- 423 Words
- 3 Pages
Good Essays